Osaic Holdings
LENZ

Osaic Holdings’s LENZ Therapeutics LENZ Stock Holding History

Osaic Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.84K Sell
1,075
-1,023
-49% -$14.4K ﹤0.01% 6302
2025
Q4 		$33.6K Sell
2,098
-236
-10% -$6.88K ﹤0.01% 5518
2025
Q3 		$108K Buy
2,334
+1,166
+100% +$42.9K ﹤0.01% 4717
2025
Q2 		$34.2K Buy
1,168
+1,116
+2,146% +$30.4K ﹤0.01% 5315
2025
Q1 		$1.34K Buy
52
+50
+2,500% +$1.23K ﹤0.01% 6731
2024
Q4 		$57 Hold
2
– – ﹤0.01% 7280
2024
Q3 		$47 Hold
2
– – ﹤0.01% 7300
2024
Q2 		$35 Hold
2
– – ﹤0.01% 7319
2024
Q1 		$45 Sell
2
-189
-99% -$3.93K ﹤0.01% 7086
2023
Q4 		$3.51K Sell
191
-189
-50% -$3.12K ﹤0.01% 6316
2023
Q3 		$6.6K Buy
380
+189
+99% +$3.29K ﹤0.01% 6136
2023
Q2 		$3.48K Sell
191
-250
-57% -$5K ﹤0.01% 6465
2023
Q1 		$7.57K Hold
441
– – ﹤0.01% 6133
2022
Q4 		$10.1K Buy
441
+2
+0.5% +$46 ﹤0.01% 5915
2022
Q3 		$10K Hold
439
– – ﹤0.01% 6027
2022
Q2 		$9K Buy
439
+250
+132% +$5.57K ﹤0.01% 6183
2022
Q1 		$7K Hold
189
– – ﹤0.01% 6352
2021
Q4 		$16K Hold
189
– – ﹤0.01% 5959
2021
Q3 		$22K Buy
+189
New +$28K ﹤0.01% 5716

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Osaic Holdings's LENZ Position: Q1 2026 in Review

Osaic Holdings reduced its LENZ Therapeutics (LENZ) stake by 49% in Q1 2026, selling an estimated $14.4K and leaving 1,075 shares worth $9.84K. The position accounts for ﹤0.01% of the portfolio, ranked #6302.

Osaic Holdings first reported a position in LENZ in Q3 2021 and has held it in 19 quarters since. The position peaked at $108K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Osaic Holdings held 1,075 shares of LENZ Therapeutics worth $9.84K as of Q1 2026.
  • Osaic Holdings sold 1,023 LENZ Therapeutics shares in Q1 2026, an estimated $14.4K.
  • LENZ Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6302 holding.
  • Osaic Holdings first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Osaic Holdings's LENZ Therapeutics position peaked at $108K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.